NO20084897L - Ny forbindelse med affinitet til amuloid - Google Patents

Ny forbindelse med affinitet til amuloid

Info

Publication number
NO20084897L
NO20084897L NO20084897A NO20084897A NO20084897L NO 20084897 L NO20084897 L NO 20084897L NO 20084897 A NO20084897 A NO 20084897A NO 20084897 A NO20084897 A NO 20084897A NO 20084897 L NO20084897 L NO 20084897L
Authority
NO
Norway
Prior art keywords
compound
affinity
carbon
represented
amuloid
Prior art date
Application number
NO20084897A
Other languages
English (en)
Norwegian (no)
Inventor
Daisaku Nakamura
Shigeyuki Tanifuji
Shinya Takasaki
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of NO20084897L publication Critical patent/NO20084897L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20084897A 2006-04-28 2008-11-20 Ny forbindelse med affinitet til amuloid NO20084897L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006124811 2006-04-28
PCT/JP2007/059048 WO2007125988A1 (fr) 2006-04-28 2007-04-26 Nouveau compose ayant une affinite envers un amyloide

Publications (1)

Publication Number Publication Date
NO20084897L true NO20084897L (no) 2009-01-15

Family

ID=38655513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084897A NO20084897L (no) 2006-04-28 2008-11-20 Ny forbindelse med affinitet til amuloid

Country Status (16)

Country Link
US (2) US8022207B2 (fr)
EP (1) EP2022792B1 (fr)
JP (1) JP5048655B2 (fr)
KR (1) KR20080112343A (fr)
CN (1) CN101472923A (fr)
AT (1) ATE493410T1 (fr)
AU (1) AU2007244313B2 (fr)
CA (1) CA2657312A1 (fr)
DE (1) DE602007011601D1 (fr)
ES (1) ES2355079T3 (fr)
IL (1) IL194889A0 (fr)
NO (1) NO20084897L (fr)
NZ (1) NZ572741A (fr)
RU (1) RU2008147002A (fr)
TW (1) TW200803903A (fr)
WO (1) WO2007125988A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE535527T1 (de) 2006-05-19 2011-12-15 Nihon Mediphysics Co Ltd Verbindung mit affinität zu amyloid
JPWO2008059714A1 (ja) * 2006-11-17 2010-03-04 日本メジフィジックス株式会社 新規アミロイド親和性化合物
TW200823211A (en) 2006-11-30 2008-06-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
CA2704027A1 (fr) * 2007-10-26 2009-04-30 Nihon Medi-Physics Co., Ltd. Nouveau compose presentant une affinite pour l'amyloide
KR20100094478A (ko) * 2007-10-30 2010-08-26 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물의 사용 및 제조 방법
EP2218464A1 (fr) * 2009-02-11 2010-08-18 Technische Universität München Composés pour la mesure non invasive d'agrégats de peptides amyloïdes
US9926316B2 (en) * 2016-03-03 2018-03-27 The Cleveland Clinic Foundation Antitumor derivatives for differentiation therapy
CN108822105A (zh) * 2018-08-14 2018-11-16 河南师范大学 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727145A (en) * 1986-09-22 1988-02-23 Ortho Pharmaceutical Corporation 2- Or 3- aryl substituted imidazo [1,2-a]pyridines
US4833149A (en) * 1986-09-22 1989-05-23 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines
US4871745A (en) * 1986-09-22 1989-10-03 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
EP0859642A2 (fr) * 1995-10-17 1998-08-26 G.D. Searle & Co. Procede de detection de la cyclooxygenase-2
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
EP1105163A4 (fr) * 1998-08-20 2003-05-02 Univ California Procede de marquage pour plaques beta-amyloide et degenerescence neurofibrillaire
US20010051632A1 (en) * 2000-03-31 2001-12-13 Wenying Chai Phenyl-substituted indolizines and tetrahydroindolizines
US6514969B2 (en) * 2000-08-16 2003-02-04 Boehringer Ingelheim Pharma Kg β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions
DE10040016A1 (de) 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2002016333A2 (fr) * 2000-08-24 2002-02-28 University Of Pittsburgh Derives de thioflavine utilises dans un diagnostic antemortem de la maladie d'alzheimer, imagerie in vivo et prevention du depot d'amyloide
MXPA03007595A (es) * 2001-02-26 2003-12-04 Bristol Myers Squibb Pharma Co Analogos de acido ascorbico para metalorradiofarmaceuticos.
US6596731B2 (en) * 2001-03-27 2003-07-22 Hoffmann-La Roche Inc. Substituted imidazo[1,2-A] pyridine derivatives
TWI245764B (en) * 2001-04-23 2005-12-21 Hank F Kung Amyloid plaque aggregation inhibitors and diagnostic imaging agents
JP4436928B2 (ja) * 2001-08-27 2010-03-24 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア スチルベン誘導体、およびアミロイド斑の結合および画像化のためのその使用
GB0205281D0 (en) * 2002-03-06 2002-04-17 Novartis Ag Organic compounds
EP1356827A1 (fr) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Préparation d'une solution de 2-18F-fluoro-2-déoxy-D-glucose (18F-FDG)
AU2003242233A1 (en) 2002-06-12 2003-12-31 Bf Research Institute, Inc. Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation
CA2496633A1 (fr) * 2002-08-30 2004-04-29 Bf Research Institute, Inc. Sondes de diagnostic et remedes contre des maladies presentant une accumulation de la proteine du prion et methode de marquage
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
NZ548098A (en) * 2003-12-31 2010-05-28 Schering Plough Ltd Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
ATE535527T1 (de) * 2006-05-19 2011-12-15 Nihon Mediphysics Co Ltd Verbindung mit affinität zu amyloid
KR20090025282A (ko) 2006-06-21 2009-03-10 니혼 메디피직스 가부시키가이샤 신규 아밀로이드 친화성 화합물
JPWO2008059714A1 (ja) 2006-11-17 2010-03-04 日本メジフィジックス株式会社 新規アミロイド親和性化合物
TW200823211A (en) * 2006-11-30 2008-06-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
TW200918102A (en) * 2007-10-24 2009-05-01 Nihon Mediphysics Co Ltd Novel compound having affinity for amyloid
CA2704027A1 (fr) * 2007-10-26 2009-04-30 Nihon Medi-Physics Co., Ltd. Nouveau compose presentant une affinite pour l'amyloide
EP2216050A4 (fr) * 2007-10-30 2012-11-21 Nihon Mediphysics Co Ltd Utilisation de nouveaux composés à affinité pour les substances amyloïdes et leur procédé de production

Also Published As

Publication number Publication date
DE602007011601D1 (de) 2011-02-10
CN101472923A (zh) 2009-07-01
EP2022792A1 (fr) 2009-02-11
KR20080112343A (ko) 2008-12-24
US20110201808A1 (en) 2011-08-18
AU2007244313B2 (en) 2011-09-08
EP2022792A4 (fr) 2009-11-11
AU2007244313A1 (en) 2007-11-08
EP2022792A8 (fr) 2009-04-29
RU2008147002A (ru) 2010-06-10
US8022207B2 (en) 2011-09-20
JP5048655B2 (ja) 2012-10-17
IL194889A0 (en) 2011-08-01
ES2355079T3 (es) 2011-03-22
CA2657312A1 (fr) 2007-11-08
ATE493410T1 (de) 2011-01-15
TW200803903A (en) 2008-01-16
WO2007125988A1 (fr) 2007-11-08
NZ572741A (en) 2010-07-30
US20100249407A1 (en) 2010-09-30
EP2022792B1 (fr) 2010-12-29
JPWO2007125988A1 (ja) 2009-09-10

Similar Documents

Publication Publication Date Title
IL195378A0 (en) Radioactive substituted heterocycle derivative and diagnostic agent for alzheimer's containing it
NO20084897L (no) Ny forbindelse med affinitet til amuloid
NO20090233L (no) Ny sammensetning som har affinitet for amyloid
IL198995A0 (en) Novel compound having affinity for amyloid
DK1740584T5 (da) Kondenseret chinolinderivat og anvendelse deraf
SG161217A1 (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
BRPI0609121B8 (pt) 1h-benzimidazol-4-carboxamidas substituídas com um carbono quaternário na posição 2
TW200738666A (en) Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
MX2008014898A (es) Composicion para el diagnostico de enfermedades relacionadas con amiloides.
EA200801063A1 (ru) Диароматические амины
WO2007112914A3 (fr) Modulation de la céramide kinase
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
BRPI0619894B8 (pt) composto de amina e composição farmacêutica
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение
ECSP088374A (es) Formulacion de aerosol para inhalacion
WO2008063548A3 (fr) Dérivés de 3-(hétéro)arylisoquinolinamine substitués en position 5, 6, ou 7 et utilisation thérapeutique de ceux-ci
CR10267A (es) Agente terapéutico o profiláctico para el síndrome de colon irritable
WO2009106552A3 (fr) Agents de contraste
TW200702352A (en) Curing aid agent used for epoxy resin
TH105093A (th) อนุพันธ์ของไอโซซาโซล-อิมาดาโซล
TH80189B (th) สารประกอบ 2-มอร์โฟลิโน-4-ไพริมิโดน
TH82152A (th) สารประกอบซับสทิทิวเทด n-ซัลโฟนิลอะมิโนเบนซิล-2-ฟีนอกซิแอเซแทมีด
TH105093B (th) อนุพันธ์ของไอโซซาโซล-อิมิดาโซล
TH88755B (th) สารประกอบทางเคมี

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application